Skip to main navigation menu Skip to main content Skip to site footer

Tuberculosis and pregnancy, infection beyond

Tuberculosis y embarazo, más allá de una infección





Section
Review Articles

How to Cite
Aránzazu Ceballos, A. D., & Martínez Sanchez, L. M. (2016). Tuberculosis and pregnancy, infection beyond. Archivos De Medicina (Manizales), 16(1), 155-166. https://doi.org/10.30554/archmed.16.1.1003.2016
Download Citation

Dimensions
PlumX

How to Cite

Aránzazu Ceballos, A. D., & Martínez Sanchez, L. M. (2016). Tuberculosis and pregnancy, infection beyond. Archivos De Medicina (Manizales), 16(1), 155-166. https://doi.org/10.30554/archmed.16.1.1003.2016

Download Citation

Lina María Martínez Sanchez

Most read articles by the same author(s)

<< < 2 

Tuberculosis (TB) is an infectious disease, chronic, transmitted by a microorganism called M. tuberculosis. The disease primarily affects the lungs, but can potentially compromise any organ of the human. TB is a public health problem that affects pregnant women worldwide. The most recent report of the WHO "Global Tuberculosis Report" estimates that each year 9,6 million people become infected, of this 3.2 millions are mostly women in a reproductive age and 480,000 of these women die each year from TB. Pregnant women who acquire this infection, show a series of similar symptoms than in women who are not pregnant; but the diagnosis becomes a challenge due to a number of symptoms such as anorexia, fatigue, lethargy among another symtoms shared by the TB infection and pregnancy Although pregnancy by itself is not a predisposing factor for acquiring TB infection, the coexistence of both conditions leads to an increase in obstetric complications such as spontaneous abortions, perinatal mortality, preeclampsia, low birth weight among others, hence the rapid and effective treatment is vital to preserve the health of the mother and fetus.


Article visits | PDF visits


Downloads

Download data is not yet available.
  1. Daniel TM. The history of tuberculosis. Respir Med.
  2. ;100(11):1862–70.
  3. Instituto Nacional de Salud INS. Protocolo de Vigilancia
  4. en Salud Pública: Tuberculosis. 2014;1–36.
  5. Oluwashola C, Ayodeji F, Omiyale O, Venyo AK. Tuberculosis
  6. in Pregnancy : A Review of Literature.
  7. Nov Sci Int J Med Sci. 2013;3(4):333–8.
  8. Ministerio de Salud y Protección Social. Actualización
  9. de los lineamientos para el manejo pragmático
  10. de Tuberculosis y Lepra en Colombia. 2015.
  11. p. 1–30.
  12. Bates M, Ahmed Y, Kapata N, Maeurer M, Mwaba
  13. P, Zumla A. Perspectives on tuberculosis in pregnancy.
  14. Int J Infect Dis; 2015;32(2015):124–7.
  15. World Health Organization. Global Tuberculosis
  16. Report 2015. WHO Libr Cat Data. 2015;1–204.
  17. Murray, PR; Rosenthal, KS; Pfaller, MA. Microbiología
  18. médica. 6a ed. Barcelona, España: Elsevier
  19. Ltd; 2009. p 277-281.
  20. Loto, OM; Awowole, I. Tuberculosis in pregnancy:
  21. A review. Journal of Pregnancy. 2012. p. 1–5.
  22. Brown, J; Capocci, S; Smith, C; Morris, S; Abubakar,
  23. I; Lipman, M. Health status and quality of life in
  24. tuberculosis. Int J Infect Dis. 2015;32(2015):68–75.
  25. Mathad, JS; Gupta, A. Tuberculosis in Pregnant
  26. and Postpartum Women: Epidemiology, Management,
  27. and Research Gaps. Clin Infect Dis.
  28. ;55(11):1532–49.
  29. Sugarman, J; Colvin, C; Moran, AC; Oxlade, O.
  30. Tuberculosis in pregnancy: an estimate of the
  31. global burden of disease. Lancet Glob Heal.
  32. ;2(12):710–6.
  33. Bates, M; Ahmed, Y; Kapata, N; Maeurer, M; Mwaba,
  34. P; Zumla, A. Perspectives on tuberculosis in pregnancy.
  35. International Journal of Infectious Diseases.
  36. 32:124-127.
  37. Baquero-Artigao, F; Mellado, M; del Rosal, T; T,
  38. Noguera, A; Goncé, A; de la Calle, M. Guía de la
  39. Sociedad Española de Infectología Pediátrica
  40. sobre tuberculosis en la embarazada y el recien
  41. nacido (I): epidemiología y diagnóstico. Tuberculosis
  42. congénita. An Pediatr. 2015;1–8.
  43. Morales, D; Fernández, S. Tuberculosis en embarazo
  44. y repercusiones neonatales. Rev Médica Costa
  45. Rica y Centroamérica. 2013;70(606):319–23.
  46. Macedo, MA; Flores, C; Rodríguez, DS; Martínez,
  47. GT; Gutiérrez, OV; Eduardo, C; et al. Perinatal commitment
  48. of pregnant with tuberculosis , Hospital
  49. Universitario “ Dr . José Eleuterio González ”, en
  50. Monterrey , Nuevo León, Mexico 2004-2012. Rev
  51. Fac Salud. 2013;13–8.
  52. Hiriart, BJ; Varas, CJ; Jiménez, GJ. Tuberculosis
  53. en el embarazo. Rev Obs Ginecol - Hosp Santiago
  54. Oriente Dr Luis Tisné Brousse. 2006;1(2):140–4.
  55. Molina, RL; Diouf, K; Nour, NM. Tuberculosis and
  56. the Obstetrician- Gynecologist : A Global Perspective.
  57. Rev Obstet Gynecol. 2013;6(3):174–81.
  58. Snider, D. Pregnancy and Tuberculosis. Chest.
  59. ;86(3):10–3.
  60. Scheafer, G; Zervoudakis, IA; Fuchs, FF; David, S.
  61. Pregnancy and pulmonary tuberculosis. Obstetrics
  62. and gynecology. 1975; 46(6):706-15.
  63. Santín, M; Navas, E. Tuberculosis in special populations.
  64. Enferm infecc Microbiol Clin. 2011;29(Supl
  65. :20–5.
  66. Getahun, H; Sculier, D; Sismanidis, C; Grzemska, M;
  67. Raviglione, M. Prevention, diagnosis, and treatment
  68. of tuberculosis in children and mothers:
  69. Evidence for action for maternal, neonatal, and
  70. child health services. J Infect Dis. 2012;205(SUPPL.
  71. :216–27.
  72. Zenner, D; Kruijshaar, ME; Andrews, N; Abubakar,
  73. I. Risk of tuberculosis in pregnancy: A national,
  74. primary care-based cohort and self-controlled
  75. case series study. Am J Respir Crit Care Med.
  76. ;185(7):779–84.
  77. Wilson, EA; Thelin, TJ; Dilts, PV. Tuberculosis
  78. complicated by pregnancy. Am J Obstet Gynecol.
  79. ; 115: 526-9.
  80. Ormerod P. Tuberculosis in pregnancy and the
  81. puerperium. Thorax. 2001;56(6):494–9.
  82. Hoffmann, CJ; Variava, E; Rakgokong, M; Masonoke,
  83. K; van der Watt, M; Chaisson, RE; et al. High
  84. Prevalence of Pulmonary Tuberculosis but Low
  85. Sensitivity of Symptom Screening among HIVInfected
  86. Pregnant Women in South Africa. PLoS
  87. One. 2013;8(4):8–12.
  88. American Thoracic Society. Targeted Tuberculin
  89. Testing and Treatment of Latent tuberculosis
  90. infection. Am Thorac Soc. 2000;161(3):221–47.
  91. Centers for Disease Control and Prevention. National
  92. Shortage of Purified-Protein Derivate Tuberculin
  93. Products. MMWR. 2008;57(42):1148–51.
  94. Cohn, D; O’Brien, R; Geiter, L. Targeted tuberculin
  95. testing and treatment of latent tuberculosis infection.
  96. MMWR 2000;49(RR-6):1–51.
  97. Jonnalagadda, SR; Brown, E; Lohman-Payne, B;
  98. Wamalwa, D; Farquhar, C; Tapia, K; et al. Consistency
  99. of mycobacterium tuberculosis-specific
  100. interferon-gamma responses in HIV-1-infected
  101. women during pregnancy and postpartum. Infect
  102. Dis Obstet Gynecol. 2012;2012:1–7.
  103. Menzies, D; Pai, M; Comstock, G. Meta-analysis :
  104. New Tests for the Diagnosis of Latent Tuberculosis
  105. Infection : Areas of Uncertainty and
  106. Recommendations for Research. Ann Intern Med.
  107. ;146:340–54.
  108. Kowada, A. Cost effectiveness of interferon ɣ
  109. release assay for TB screening of HIV positive
  110. pregnant women in low TB incidence countries.
  111. J Infect. 2014;68(1):32–42.
  112. Knight, M; Kurinczuk, JJ; Nelson-Piercy, C; Spark,
  113. P; Brocklehurst, P. Tuberculosis in pregnancy
  114. in the UK. BJOG An Int J Obstet Gynaecol.
  115. ;116(4):584–8.
  116. Maynard-Smith, L; Larke, N; Peters, JA; Lawn, SD.
  117. Diagnostic accuracy of the Xpert MTB/RIF assay
  118. for extrapulmonary and pulmonary tuberculosis
  119. when testing non-respiratory samples: a systematic
  120. review. BMC Infect Dis. 2014;14(709):1–15.
  121. Bates, M; Ahmed, Y; Chilukutu, L; Tembo, J; Cheelo,
  122. B; Sinyangwe, S; et al. Use of the Xpert MTB/RIF
  123. assay for diagnosing pulmonary tuberculosis comorbidity
  124. and multidrug-resistant TB in obstetrics
  125. and gynaecology inpatient wards at the University
  126. Teaching Hospital, Lusaka, Zambia. Tropical Medicine
  127. and Internacional Health. 2013.18(9)1134-40.
  128. Cox, HS; Mbhele, S; Mohess, N; Whitelaw, A; Muller,
  129. O; Zemanay, W. et al. Impact of Xpert MTB/RIF for
  130. TB Diagnosis in a Primary Care Clinic with High
  131. TB and HIV Prevalence in South Africa: A Pragmatic
  132. Randomised Trial. PLoS Med. 2014;11(11):1–
  133. Harapan, H; Fitra, F; Ichsan, I; Mulyadi, M; Miotto,
  134. P; Hasan, NA et al. The roles of microRNAs on
  135. tuberculosis infection: Meaning or myth? Tuberculosis
  136. ;93(6):596–605.
  137. Steingart, KR; Schiller, I; Horne, DJ; Pai, M; Boehme,
  138. CC; Dendukuri, N. Xpert® MTB/RIF assay for pulmonary
  139. tuberculosis and rifampicin resistance in
  140. adults. Cochrane database Syst Rev. 2014;1(1):1–
  141. Centers for Disease Control and Prevention. Availability
  142. of an assay for detecting Mycobacterium
  143. tuberculosis, including rifampin-resistant strains,
  144. and considerations for its use - United States,
  145. MMWR. 2013;62(41):821–7.
  146. Frieden, TR; Sterling, TR; Munsiff, SS; Watt, CJ;
  147. Dye, D. Tuberculosis. The Lancet.2003; 362(9387):
  148. –899.
  149. Diaz, M; Cordero, J; Gutierrez, M; Conde, Y. Tuberculosis
  150. congénita: presentación de un caso
  151. clínico y revisión de la literatura. Rev Soc Bol
  152. Ped. 2015;54(1):14–7.
  153. Mnyani, CN; McIntyre, JA. Tuberculosis in pregnancy.
  154. BJOG An Int J Obstet Gynaecol. 2011;118(2):226–
  155. Cantwell, M; Shehab, Z; Costello, A; Sands, L; Green,
  156. W. Brief report: Congenital tuberculosis. NEJM.
  157. ;330(15):1051–4.
  158. Centers for Disease Control and Prevention. Recommendations
  159. for Use of an Isoniazid-Rifapentine
  160. Regimen With Direct Observation to treat Latent
  161. Mycobacteriom tuberculosis Infection. MMWR].
  162. ;60(48):1641–72.
  163. Bothamley, G. Drug treatment for tuberculosis
  164. during pregnancy: safety considerations. Drug
  165. Saf. 2001;24(7):553–65.
  166. Yen, YF; Chung, MS; Hu, HY; Lai, YJ; Huang, LY;
  167. Lin, YS et al. Association of Pulmonary Tuberculosis
  168. and Ethambutol With Incident Depressive
  169. Disorder. J Clin Psychiatry. 2015;76(4):505–11.
  170. Shin, S; Guerra, D; Rich, M; Seung, KJ; Mukherkjee,
  171. J; Joshep, K; et al. Treatment of multidrug-resistant
  172. tuberculosis during pregnancy: a report of
  173. cases. Clin Infect Dis. 2003;36(8):996-1003.
  174. Bantubani, N; Kabera, G; Connolly, C; Rustomjee, R;
  175. Reddy, T; Cohen, T et al. High rates of potentially
  176. infectious tuberculosis and multidrug-resistant tuberculosis
  177. (MDR-TB) among hospital inpatients in
  178. KwaZulu Natal, South Africa indicate risk of nosocomial
  179. transmission. PLoS One. 2014;9(3):1–7.
  180. Ormerod, LP. Multidrug-resistant tuberculosis
  181. (MDR-TB): Epidemiology, prevention and treatment.
  182. Br Med Bull. 2005;73-74:17–24.
  183. Nunn, AJ; Rusen, ID; Van Deun, A, Torrea G, Phillips
  184. PP, Chiang CY, et al. Evaluation of a standardized
  185. treatment regimen of anti-tuberculosis drugs for
  186. patients with multi-drug-resistant tuberculosis
  187. (STREAM): study protocol for a randomized controlled
  188. trial. Trials. 2014;15(353):1–10.
  189. Palacios, E; Dallman, R; Muñoz, M; Hurtado,
  190. R; Chalco, K; Guerra, D et al. Drug-resistant
  191. tuberculosis and pregnancy: treatment outcomes
  192. of 38 cases in Lima, Peru. Clin Infect Dis.
  193. ;48(10):1413–9.
  194. Hillery, N; Groessl, EJ; Trollip, A; Catanzaro, D;
  195. Jackson, L; Rodwell, TC et al. The Global Consortium
  196. for Drug-resistant Tuberculosis Diagnostics
  197. (GCDD): design of a multi-site, headto-
  198. head study of three rapid tests to detect
  199. extensively drug-resistant tuberculosis. Trials.
  200. ;15(434):1–13.